Adaptation of β-cell mass to substrate oversupply: Enhanced function with normal gene expression

American Journal of Physiology - Endocrinology and Metabolism

Volumn 280, Issue 5 43-5, 2001, Pages

  Steil, Garry M ^a,b   Trivedi, Nitin ^a   Jonas, Jean Christophe ^a   Hasenkamp, Wendy M ^a   Sharma, Arun ^a   Bonner Weir, Susan ^a   Weir, Gordon C ^a  

^a JOSLIN DIABETES CENTER   (United States)

^b MEDTRONIC INC   (United States)

Author keywords

Insulin resistance; Insulin secretion; Maturity onset diabetes of the young; Mitosis; cell

Indexed keywords

GLUCOSE; HEPARIN; INSULIN; INTRALIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; INNER CELL MASS; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

EID: 0035008598     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2001.280.5.e788     Document Type: Article

References (50)

1. Balkan B and Dunning BE. Muscarinic stimulation maintains in vivo insulin secretion in response to glucose after prolonged hyperglycemia. Am J Physiol Regulatory Integrative Comp Physiol 268: R475-R479, 1995.
2. Barnett V and Lewis T. Outliers in Sstatistical Data. New York: Wiley, 1994.
3. Bernard C, Thibault C, Berthault MF, Magnan C, Saulnier C, Portha B, Pralong WF, Penicaud L, and Ktorza A. Pancreatic β-cell regeneration after 48-h glucose infusion in mildly diabetic rats is not correlated with functional improvement. Diabetes 47: 1058-1065, 1998.
4. Bevilacqua S, Bonadonna RC, Buzzigoli G, Boni C, Ciociaro D, Maccari F, Giorico MA, and Ferrannini E. Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metabolism 36: 502-506, 1987.
5. Bollheimer LC, Skelly RH, Chester MW, McGarry JD, and Rhodes CJ. Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 101: 1094-1101, 1998.
6. Bonner-Weir S. Regulation of pancreatic β-cell mass in vivo. Recent Prog Horm Res 49: 91-104, 1994.
7. Bonner-Weir S, Deery D, Leahy JL, and Weir GC. Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes 38: 49-53, 1989.
8. Chalkley SM, Hettiarachchi M, Chisholm DJ, and Kraegen EW. Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. Metabolism 47: 1121-1126, 1998.
9. Chen C, Bumbalo L, and Leahy JL. Increased catalytic activity of glucokinase in isolated islets from hyperinsulinemic rats. Diabetes 43: 684-689, 1994.
10. Consoli A, Nurjhan N, Reilly JJ Jr, Bier DM, and Gerich JE. Mechanism of increased gluconeogenesis in non-insulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. J Clin Invest 86: 2038-2045, 1990.
11. DeFronzo RA, Bonadonna RC, and Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15: 318-368, 1992.
12. Dobbins RL, Chester MW, Daniels MB, McGarry JD, and Stein DT. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes 47: 1613-1618, 1998.
13. Eaton RP, Allen RC, Schade DS, Erickson KM, and Standefer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab 51: 520-528, 1980.
14. Finegood DT, Scaglia L, and Bonner-Weir S. Dynamics of β-cell mass in the growing rat pancreas: estimation with a simple mathematical model. Diabetes 44: 249-256, 1995.
15. Giddings SJ, Carnaghi LR, and Shalwitz RA. Hypoglycemia but not hyperglycemia induces rapid changes in pancreatic β-cell gene transcription. Am J Physiol Endocrinol Metab 265: E259-E266, 1993.
16. Gremlich S, Bonny C, Waeber G, and Thorens B. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J Biol Chem 272: 30261-30269, 1997.
17. Habener JF and Stoffers DA. A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus. Proc Assoc Am Phys 110: 12-21, 1998.
18. Hertz R, Magenheim J, Berman I, and Bar-Tana J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 392: 512-516, 1998.
19. Hirose H, Lee YH, Inman LR, Nagasawa Y, Johnson JH, and Unger RH. Defective fatty acid-mediated β-cell compensation in Zucker diabetic fatty rats: pathogenic implications for obesity-dependent diabetes. J Biol Chem 271: 5633-5637, 1996.
20. Jonas JC, Sharma A, Hasenkamp WM, Ilkova H, Laybutt DR, Bonner-Weir S, and Weir GC. Chronic hyperglycemia triggers loss of pancreatic β cell differentiation in an animal model of diabetes. J Biol Chem 274: 14112-14121, 1999.
21. Jonsson J, Carlsson L, Edlund T, and Edlund H. Insulin-promoter-factor I is required for pancreatic development in mice. Nature 371: 606-609, 1994.
22. Kahn SE, Beard JC, Schwartz MW, Ward WK, Ding HL, Bergman RN, Taborsky GJJ, and Porte DJ. Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 38: 562-568, 1989.
23. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, and Palmer JP. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42: 1663-1672, 1993.
24. Kirk RE. Experimental Design: Procedures for the Behavior Sciences. Pacific Grove, CA: Brooks/Cole, 1982.
25. Laury MC, Takao F, Bailbe D, Penicaud L, Portha B, Picon L, and Kuikka J. Differential effects of prolonged hyperglycemia on in vivo and in vitro insulin secretion in rats. Endocrinology 128: 2526-2533, 1991.
26. Laybutt DR, Chisholm DJ, and Kraegen EW. Specific adaptations in muscle and adipose tissue in response to chronic systemic glucose oversupply in rats. Am J Physiol Endocrinol Metab 273: E1-E9, 1997.
27. Leahy JL, Bonner-Weir S, and Weir GC. Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest 81: 1407-1414, 1988.
28. Leahy JL, Bonner-Weir S, and Weir GC. Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 15: 442-455, 1992.
29. Leahy JL, Cooper HE, Deal DA, and Weir GC. Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. J Clin Invest 77: 908-915, 1986.
30. Leahy JL, Cooper HE, and Weir GC. Impaired insulin secretion associated with near normoglycemia. Study in normal rats with 96-h in vivo glucose infusions. Diabetes 36: 459-464, 1987.
31. Leahy JL and Weir GC. Evolution of abnormal insulin secretory responses during 48-h in vivo hyperglycemia. Diabetes 37: 217-222, 1988.
32. Leahy JL and Weir GC. Beta-cell dysfunction in hyperglycaemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level. Diabetologia 34: 640-647, 1991.
33. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, and Unger RH. β-Cell lipotoxicity in the pathogenesis of non-insulin dependent diabetes of obese rats: impairment in adipocyte-β-cell relationships. Proc Natl Acad Sci USA 91: 10878-10882, 1994.
34. Magnan C, Collins S, Berthault MF, Kassis N, Vincent M, Gilbert M, Penicau L, Ktorza A, and Assimacopoulos-Jeannet F. Lipid infusion lowers sympathetic nervous activity and leads to increased β-cell responsiveness to glucose. J Clin Invest 103: 413-419, 1999.
35. Magnusson I, Rothman DL, Katz LD, Shulman RG, and Shulman GI. Increased rate of gluconeogenesis in type II diabetes mellitus. J Clin Invest 90: 1323-1327, 1992.
36. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, and Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340: 925-929, 1992.
37. Mason TM, Goh T, Tchipahvili V, Sandhu H, Gupta N, Lewis GF, and Giacca A. Prolonged elevation of plasma free fatty acids desensitize the insulin secretory response to glucose in vivo in rats. Diabetes 48: 524-530, 1999.
38. Matschinsky FM. Glucokinase as glucose sensor and metabolic generator in pancreatic β-cell signal transduction. Diabetes 39: 647-652, 1990.
39. Milburn JL Jr, Hirose H, Lee YH, Nagasawa Y, Ogawa A, Ohneda M, BeltrandelRio H, Newgard CB, Johnson JH, and Unger RH. Pancreatic β-cells in obesity: evidence for induction of functional, morphological, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 270: 1295-1299, 1995.
40. Montana E, Bonner-Weir S, and Weir GC. Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozotocin diabetic C57BL/6 mice. J Clin Invest 91: 780-787, 1993.
41. Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, and Tsai MJ. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/ neuroD-deficient mice. Genes Dev 11: 2323-2334, 1997.
42. Shalwitz RA, Herbst T, Carnaghi LR, and Giddings SJ. Time course for effects of hypoglycemia on insulin gene transcription in vivo. Diabetes 43: 929-934, 1994.
43. Shimabukuro M, Zhou YT, Levi M, and Unger RH. Fatty acid-induced β cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 95: 2498-2502, 1998.
44. Stein DT, Esser V, Stevenson BE, Lane KE, Whiteside JH, Daniels MB, Chen S, and McGarry JD. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97: 2728-2735, 1996.
45. Stoffel M and Duncan SA. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4α regulates expression of genes required for glucose transport and metabolism. Proc Natl Acad Sci USA 94: 13209-13214, 1997.
46. Warnotte C, Nenquin M, and Henquin JC. Unbound rather than total concentration and saturation rather than unsaturation determine the potency of fatty acids on insulin secretion. Mol Cell Endocrinol 153: 147-153, 1999.
47. Weibel ER. Stereologic methods. In: Practical Methods for Biological Morphometry. London: Academic, 1978, p. 101-161.
48. Wisenthal SR, Sandhu H, Mccall RH, Tchipashvili V, Yoshii H, Polonsky K, Shi ZQ, Lewis GF, Mari A, and Giacca A. Free fatty acids impair hepatic insulin extraction in vivo. Diabetes 48: 766-774, 1999.
49. Woerner CA. Studies on the islands of Langerhans after continuous injection of dextrose. Anat Rec 71: 22-57, 1936.
50. Zambon A, Hashimoto SI, and Brunzell JD. Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J Lipid Res 34: 1021-1028, 1993.